A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients

NCT03066804 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2572

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: sacubitril/valsartan
DRUG: Enalapril
DRUG: Valsartan
DRUG: Placebo to match sacubitril/valsartan
DRUG: Placebo to match enalapril
DRUG: Placebo to match valsartan

Sponsor

Novartis Pharmaceuticals